Dimerix Up 154% on Exclusive License Agreement | Similarities to Neuren (NEU)

Dimerix's (DXB) share price rose 154% on October 5 after announcing an exclusive license agreement with Advanz Pharma.
The announcement drew memories to a smiliar one released by Neuren (NEU) in 2018 ... just different reactions from the market

► How to Find the BEST Small Cap Stocks
How to Find the BEST Small Cap Stocks

► What is an Appendix 4C?
What is an Appendix 4C?

► Personal and Business Inquiries
[email protected]

► Social Media
Twitter: Twitter: KneppyI

• #education
• #kneppy_invests
• #asx_stocks
• #small_caps_asx
• #growth_stocks